MIAMI, May 25, 2011 /PRNewswire/ -- ONE Bio, Corp.
("ONE" or the "Company") (OTC BB: ONBI), an innovative company
utilizing green process manufacturing to produce raw chemicals and
herbal extracts, natural and health supplements and organic
products, today announced the availability of a video tour of ONE's
China operations and an interview
with the Company's Chief Finance Manager, Stephen Song, and its VP of Operations,
Jinrong Tang. The video tour and
interview were conducted by Dave
Gentry, President of RedChip Companies, Inc., during his
recent visit to China.
Highlights of the interview include comments from Mr. Song
regarding the thoroughness of ONE's independent audit process and
details of the Company's new nutraceutical product line slated for
launch in June 2011.
The video can be viewed at the following link:
http://redchip.com/visibility/investor.asp?symbol=ONBI
About ONE Bio, Corp.
ONE Bio, Corp. ("ONE") (OTC BB: ONBI) (www.onehcorp.com),
headquartered in Miami, FL, is an
innovative company utilizing patented green process manufacturing
to produce raw chemicals and herbal extracts, natural supplements
and organic products. ONE is focused on the Asia Pacific region and the United States. Key products include widely
recognized Solanesol, CoQ10, Resveratrol and 5-HTP, organic
fertilizers, and organic bamboo health food and beverages. ONE has
experienced solid organic growth driven by a robust demand for its
products in China, Japan and the United
States.
This press release includes statements that constitute
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995 (the "Reform Act"). ONE
Bio, Corp. claims the protection of the safe-harbor for
forward-looking statements contained in the Reform Act. These
forward-looking statements are often characterized by the terms
"may," "believes," "projects," "expects," or "anticipates," and do
not reflect historical facts. Specific forward-looking statements
contained in this press release include, but are not limited to:
our successful integration of diversified growth companies, impact
of the company's expansion plan, and new business development
success, future financial results, development and acquisition of
new product lines and services, the impact of competitive products
or pricing from technological changes, the effect of economic
conditions and other uncertainties. The forward-looking statements
contained herein involve risks and uncertainties that could cause
actual results to differ materially from the expectations contained
in any such forward-looking statements. These risks include, but
are not limited to: failure to manage operating expenses or
integrate new companies and/or technologies, each of which could
have a material impact on our business, our financial results, and
the company's stock price. These risks and other factors are
detailed in the Company's regular filings with the U.S. Securities
and Exchange Commission. Most of these factors are difficult to
predict accurately and are generally beyond the Company's control.
Forward-looking statements speak only as to the date they are made
and ONE Bio, Corp. does not undertake to update forward-looking
statements to reflect circumstances or events that occur after the
date the forward-looking statements are made.
Company Contact:
Marius Silvasan
CEO
Tel. + 786-288-3488
Email: msilvasan@onehcorp.com
Investor Relations Contact:
Investor Relations & Corporate Communications
Tel. +888-676-4445
Email: ir@onehcorp.com
Dave Gentry, U.S.
RedChip Companies, Inc.
Tel: +1-800-733-2447, Ext. 104
Email: info@redchip.com
SOURCE ONE Bio, Corp.